Skip to content
Case File
d-27503House OversightOther

Equity Research Report on Zain KSA Valuation and Risks

Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #016191
Pages
1
Persons
1

Summary

The passage is a standard financial analyst note containing valuation assumptions and risk factors for a telecom company. It mentions no high‑profile political figures, government agencies, or controv DCF valuation targets SAR 12.2 with 11% discount rate. Assumes repayment of a deferred royalty loan from 2013 starting 2021. Identifies risks: MVNO pricing pressure, SAR620 mn tax claim, arbitration

This document is from the House Oversight Committee Releases.

View Source Collection

Persons Referenced (1)

Tags

valuationtelecommunicationsrisk-assessmentfinancial-analysiszain-ksahouse-oversightcorporate-riskfinance
Share
PostReddit

Related Documents (6)

House OversightOtherNov 11, 2025

Cannabis Investment Report – December 2017 Financial Metrics

The document is a financial summary of cannabis‑related public companies with valuation multiples and revenue figures. It contains no references to political figures, government agencies, foreign lead Provides LTM and forward revenue, EBITDA, and enterprise value for several cannabis firms. Lists stock tickers and market percentages for each company. Notes methodology for handling negative or extr

1p
House OversightOtherNov 11, 2025

Internet Sector Valuation Multiples Report – No Evident Investigative Leads

The document contains only market valuation data and chart references for internet, e‑commerce, media, and travel stocks. It mentions no individuals, transactions, government agencies, or potential mi Provides EV/EBITDA and P/E multiples for various internet‑related sectors as of April 2017. Lists specific valuation multiples for companies such as AMZN, WIX, EBAY, GOOG, FB, TWTR, TRIP, EXPE Cites

1p
House OversightOtherNov 11, 2025

Equity research price objectives and risk assessments for GoPro, GrubHub, LendingTree, Match Group, and Bank of America

The passage contains only analyst valuation metrics and generic market risk factors for publicly traded companies. It does not mention any high‑profile individuals, government agencies, financial misc Analyst sets price targets based on 2018E EBITDA multiples. Identifies product, competitive, and macroeconomic risks for each company. No mention of political figures, intelligence agencies, or illic

1p
House OversightOtherNov 11, 2025

Morgan Stanley Research Report on Alternative Asset Manager Valuations

The document is a standard financial research note containing valuation analysis and scenario modeling for asset managers. It contains no references to political figures, government agencies, financia Discusses C‑corp conversion and fee‑related earnings re‑rating. Provides upside/downside scenarios and sensitivity analyses for several private‑equity firms. Includes appendices with valuation tables

1p
House OversightOtherNov 11, 2025

Morgan Stanley Research KKR Sum‑of‑the‑Parts Valuation Exhibit

The document contains only internal financial modeling data for KKR with no mention of political figures, government agencies, foreign actors, or alleged misconduct. It offers no actionable investigat Provides upside/downside valuation scenarios for KKR's C‑corp conversion. Shows fee‑related earnings multiples and projected share price impacts. Cites Morgan Stanley and Thomson Reuters as data sour

1p
House OversightOtherNov 11, 2025

Oaktree Capital Group Sum‑of‑the‑Parts Valuation Analysis

The document contains only internal financial modeling data for Oaktree Capital Group, with no mention of political figures, government agencies, foreign actors, or potential misconduct. It offers no Provides SOTP valuation tables and fee‑related earnings multiples. Shows projected share price ranges under various conversion scenarios. Cites Morgan Stanley and Thomson Reuters data sources.

1p

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.